The observed tumor growth inhibition after treatment with imatinib and vitamin D analogs, PRI-2191 and PRI-2205, could be the result of apoptotic cell death, since downregulation of anti-apoptotic Bcl-2 protein was observed. This evidence concerns the gene BCL2 and neoplasm.